Good morning :)
Place Order
Add to Watchlist

HVAX Technologies Ltd

HVAX

HVAX Technologies Ltd

HVAX
Health CarePharmaceuticals
SmallcapWith a market cap of ₹166 cr, stock is ranked 2,655
High RiskStock is 5.38x as volatile as Nifty
578.900.03% (+0.20)
578.900.03% (+0.20)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹166 cr, stock is ranked 2,655
High RiskStock is 5.38x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹166 cr, stock is ranked 2,655
High RiskStock is 5.38x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
5.45
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.906.610.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

HVAX Technologies Ltd specializes in modular cleanroom systems, HVAC products, and electrical panels, serving biotech and pharmaceutical facilities with a range of engineering consultancy services.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2021FY 2022FY 2023FY 2024TTM
Total Revenue61.8368.7996.14107.47
Raw Materialssubtract43.4542.0564.1967.53
Power & Fuel Costsubtract0.080.070.090.11
Employee Costsubtract4.706.066.718.39
Selling & Administrative Expensessubtract3.085.0715.3815.88
Operating & Other expensessubtract4.028.121.010.32
Depreciation/Amortizationsubtract0.711.221.071.07
Interest & Other Itemssubtract0.560.630.701.58
Taxes & Other Itemssubtract1.521.391.793.20
EPS20.0522.5928.1048.21
DPS0.000.000.000.00
Payout ratio0.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
HVAX Technologies Ltd17.775.45
Sun Pharmaceutical Industries Ltd45.106.440.75%
Cipla Ltd29.414.520.87%
Torrent Pharmaceuticals Ltd68.5016.550.84%

Price Comparison

Compare HVAX with any stock or ETF
Compare HVAX with any stock or ETF
HVAX
Loading...

Shareholdings

Promoter Holdings Trend

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding66.65%0.00%0.56%9.37%23.42%

Jun 2024

Oct 2024

Shareholding History

JunOct0.00%9.37%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

HVAX has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
HVAX Technologies to convene board meeting

HVAX Technologies will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
NSE SME HVAX Technologies makes a decent debut

The scrip was listed at Rs 486, a premium of 6.11% over the initial public offer (IPO) price. The stock was currently down 1.23% compared to its listing price. The counter hit a high of Rs 508 and a low of Rs 461.70. About 2.46 lakh shares of the company changed hands at the counter. Hvax Technologies' IPO was subscribed 22.82 times. The issue opened for bidding on 27 September 2024 and it closed on 1 October 2024. The price band of the IPO was set at Rs 435 to Rs 458 per share. The IPO comprised fresh issue of 7,32,000 shares. The promoter and promoter group shareholding diluted to 66.65% from 90.50% pre-IPO. The company intends to utilize the net proceeds for working capital requirements and general corporate purpose. Ahead of the IPO, Hvax Technologies on 26 September 2024, raised Rs 9.48 crore from anchor investors. The board allotted 2.07 lakh shares at Rs 458 per share to 3 anchor investor. Mumbai-based Hvax Technologies offers services for engineering, procurement and construction of controlled environments and clean room infrastructure. They provide design, engineering, and consulting services specifically for pharmaceutical and healthcare companies. The company supplies various products made by third parties, including, cleanroom wall panels, cleanroom ceiling panels, covings, clean room doors, flooring systems, riser panels, etc. The company's customers include pharmaceutical companies, chemical companies, hospitals, healthcare providers, and FMCG companies. As on 31 August 2024, the company had 125 permanent employees and 21 temporary employees. The company recorded revenue from operations of Rs 106.06 crore and net profit of Rs 9.39 crore for the period as on 31 March 2024. Powered by Capital Market - Live

2 months agoCapital Market - Live